Werewolf Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:HOWL) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -14.25 M-18.95 M-15.16 M-15.16 M-11.02 M -60.29 M Cash from investing activities -123 K0000 0 Cash from financing activities 2.55 M0388 K3.27 M2.37 M 6.03 M Free cash flow -14.38 M-18.95 M-15.16 M-15.16 M-11.02 M -60.29 M

Nouvelles

Truist sees positive reaction for biotech stocks after FDA official exit

Werewolf Therapeutics explore une vente et des alternatives stratégiques

Werewolf Therapeutics explores sale and strategic alternatives

Le titre de Werewolf Therapeutics chute après l’annonce d’une réduction de 64% des effectifs

Werewolf Therapeutics stock falls after announcing 64% workforce reduction

Werewolf Therapeutics reçoit un avis du Nasdaq pour non-conformité du prix minimum

Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency

Luke Evnin, directeur de Werewolf Therapeutics, vend des actions HOWL pour 20.942€

Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock

Evnin Luke vend des actions de Werewolf Therapeutics (HOWL) pour 53.533€

Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533

Luke Evnin vend des actions de Werewolf Therapeutics (HOWL) pour 45.882$